
Danish pharmaceutical company Lundbeck aspires to be carbon neutral by 2050. It aims to reduce its emissions to one third of today's levels by the end of 2034.
The hardest element of reaching this goal will be rethinking the company's supply chain, which is currently responsible for the majority of the firm's carbon footprint.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app